382 related articles for article (PubMed ID: 30463794)
1. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release.
Gordillo-Galeano A; Mora-Huertas CE
Eur J Pharm Biopharm; 2018 Dec; 133():285-308. PubMed ID: 30463794
[TBL] [Abstract][Full Text] [Related]
2. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
Choi KO; Choe J; Suh S; Ko S
Molecules; 2016 May; 21(5):. PubMed ID: 27213324
[TBL] [Abstract][Full Text] [Related]
3. DEVELOPMENT OF SOLID LIPID NANOCARRIERS FOR ORAL DELIVERY OF CANDESERTAN CILEXETIL.
Ugurlu T; Nalbantoglu A; Sengel-Turk CT
Acta Pol Pharm; 2016 Nov; 73(6):1631-1638. PubMed ID: 29634119
[TBL] [Abstract][Full Text] [Related]
4. Vesicle-like structure of lipid-based nanoparticles as drug delivery system revealed by molecular dynamics simulations.
Khalkhali M; Mohammadinejad S; Khoeini F; Rostamizadeh K
Int J Pharm; 2019 Mar; 559():173-181. PubMed ID: 30684596
[TBL] [Abstract][Full Text] [Related]
5. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
Kovačević AB; Müller RH; Keck CM
Int J Pharm; 2020 Feb; 576():118918. PubMed ID: 31870954
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR).
Mitsutake H; Ribeiro LNM; Rodrigues da Silva GH; Castro SR; de Paula E; Poppi RJ; Breitkreitz MC
Eur J Pharm Sci; 2019 Jul; 135():51-59. PubMed ID: 31071439
[TBL] [Abstract][Full Text] [Related]
7. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
8. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
Wang T; Xue J; Hu Q; Zhou M; Luo Y
J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
[TBL] [Abstract][Full Text] [Related]
9. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
[TBL] [Abstract][Full Text] [Related]
12. Compatibility analysis of bergapten with different pharmaceutical excipients used in nanostructured lipid carriers.
Arshad S; Rehman M; Zulfiqar J; Najam S; Asim MH; Abid F
Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2879-2885. PubMed ID: 32024628
[TBL] [Abstract][Full Text] [Related]
13. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
15. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug.
My Tran KT; Vo TV; Lee BJ; Duan W; Ha-Lien Tran P; Truong-Dinh Tran T
Curr Drug Deliv; 2018; 15(4):576-584. PubMed ID: 28595530
[TBL] [Abstract][Full Text] [Related]
17. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
18. Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration.
Alcantara KP; Zulfakar MH; Castillo AL
Int J Pharm; 2019 Nov; 571():118705. PubMed ID: 31536765
[TBL] [Abstract][Full Text] [Related]
19. Natural lipids-based NLC containing lidocaine: from pre-formulation to in vivo studies.
Ribeiro LNM; Breitkreitz MC; Guilherme VA; da Silva GHR; Couto VM; Castro SR; de Paula BO; Machado D; de Paula E
Eur J Pharm Sci; 2017 Aug; 106():102-112. PubMed ID: 28558981
[TBL] [Abstract][Full Text] [Related]
20. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]